Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480215 · ClinicalTrials.gov registry record · NA
Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands
A NA study, sponsored by Cala Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05480215 is a NA study that has completed, run by Cala Health. The registered enrollment target is 20 participants.
The verdict
NCT05480215, a NA study, has completed, sponsored by Cala Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Demonstrate safety and effectiveness of symptomatic action tremor relief in the treated hand following stimulation with the Cala Trio System using the Trio+ bands as compared to the Trio bands in adults with Essential Tremor (ET) and/or Parkinson's Disease (PD) over 2 weeks.
Interventions
- DEVICE Cala Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2021-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05480215
The ClinicalTrials.gov registry entry for NCT05480215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cala Health, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cala Device is the first listed.
NCT05480215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05480215 about?
NCT05480215 is a clinical study titled "Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands". Demonstrate safety and effectiveness of symptomatic action tremor relief in the treated hand following stimulation with the Cala Trio System using the Trio+ bands as compared to the Trio bands in adults with Essential Tremor (ET) and/or Parkinson's Disease (PD) over 2 weeks.
What is the current status of trial NCT05480215?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-10-07. Estimated completion is 2021-12-16.
What interventions are being tested in trial NCT05480215?
The interventions under investigation include: Cala Device (DEVICE).
Who is sponsoring clinical trial NCT05480215?
This trial is sponsored by Cala Health, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.